Philipp E. Bartko

Physician and researcher focused on structural heart disease, valvular driven heart failure, structural heart interventions.

[RTHahnMD @hahn_rt]

Grateful to @lpbadano for invitation to write https://t.co/kEgGtrct4A
Together w/ @denisamuraru @pe_bartko @drmaisano Pepe Zamorano and @DonalErwan @ESC_Journals @EACVIPresident @escardio @ASE360 @iamritu @GilbertTangMD @ACCinTouch @HeartValveCntr @GeraldMaurer

[Philippe Pibarot @PPibarot]

In Low Gradient AS, reduced GLS, increased ECV and LGE on CMR was associated with worse outcomes.
Comprehensive myocardial characterization using cardiac magnetic resonance associates with outcomes in low gradient severe aortic stenosis https://t.co/t7CMtMX7af

[João Cavalcante @JoaoLCavalcante]

New multicenter TOPAS CMR study led by @Miho_Fukui_ and @PPibarot demonstrates the importance of phenotyping myocardial structural and function using #whyCMR in the complex group of low-gradient AS. Prognosis worsens with greater # of CMR risk markers. https://t.co/jHXKMfi8Mh

[PCRonline 🫀 @PCRonline]

Join @EdwardsLifesci in Paris or online for their #EuroPCR 2022 symposiums:
➡️"Valve in Valve and the journey starting with the first prosthesis" with @ValveDisease on May 17th
➡️"Learnings from an optimised #TAVI patient's journey" on May 18th
Sponsored post by @EdwardsLifesci

[Kardiologie MedUni Wien Forschung @KardiologieWien]

Im Rahmen der Langen Nacht der Forschung können Sie eine von unseren @KardiologieWien ExpertInnen live-kommentierte minimal-invasive Herklappen-Implantation verfolgen!

Fr 20.5. 18:00
@MedUni_Wien / AKH Hörsaalzentrum

https://t.co/dHo4L9skJd

[Denisa Muraru @denisamuraru]

GDMT titration conveys 3x higher chance to achieve improvement in secondary MR.

40% pts achieved #SMR reduction w/ ARNi and combinations of RASi, BB & MRA
Congrats @pe_bartko @ggoliasch

https://t.co/SqYhf79AwJ

#EHJCVI
@ESC_Journals
@GeraldMaurer

[Denisa Muraru @denisamuraru]

Tricuspid regurgitation: what have we learnt? #EHJCVI
🚩 New nomenclature
🚩 New classification
🚩 New grading
🚩 New imaging approaches
https://t.co/Tgcwilsurg
Fantastic leadership by @hahn_rt &collaboration @lpbadano @drmaisano @pe_bartko @DonalErwan JL Zamorano
#PCRTricuspid

[RTHahnMD @hahn_rt]

Thank you to my co-authors @lpbadano @denisamuraru @pe_bartko @drmaisano @PEPEZAMORANO and @DonalErwan: TR Review https://t.co/l1dGh8YI7g @ESC_Journals @escardio @ASE360 @echo_stepbystep @EGarciaSayan @robertomlang

[Akihisa Kataoka, MD, PhD, FESC @d_akihisa]

Excited to announce that my new provocative maneuver to detect PFO using party balloon during Saline Contrast Transthoracic Echocardiography has been published in JACC: Case Reports.

https://t.co/iUdmGljWHF

[JACC Journals @JACCJournals]

Topological mapping in secondary MR (sMR): #echofirst analysis shows importance of role of LA. Highest mortality in “small LV cavity” cluster. https://t.co/p71Eta3txG

#vhdMR #cvVHD #JACCIMG #CardioTwitter #cvImaging #HFrEF @ValveDisease @pe_bartko @g_heitzinger @ggoliasch

[Kardiologie MedUni Wien Forschung @KardiologieWien]

What are the key morphological and functional features in secondary mitral regurgitation?

@pe_bartko, @g_heitzinger, @ggoliasch et al from our @ValveDisease group present exciting novel data in @JACCJournals

https://t.co/JZG0CROvaB

[Giuseppe Biondi-Zoccai @gbiondizoccai]

"Unsupervised clustering supports the association of sMR with mortality predominantly driven by the small LV cavity phenotype, as previously suggested by a conceptional framework and termed disproportionate sMR"
https://t.co/Y1lbepWAT8

[Philippe Pibarot @PPibarot]

The association of secondary MR with mortality cannot be purely attributed to cardiac morphology alone. From @jaccjournals https://t.co/zHbVWmYeem

[CardioTomLuscher @TomLuscher]

Ever thought of preventing aortic stenosis (AS) instead having AVR or TAVI? Molecular mechanisms are unravelled and we will prevent AS like CAD. Statins do not work, but Lp(a) is a target in some, in others molecular mechanisms are deciphered - read it in the EHJ online!

[CircImaging @CircImaging]

Stress FR during LDDSE is useful for the detection of AS severity & flow reserve & is associated with outcomes following aortic valve intervention @AVamvakidou @PPibarot @E_Guzzetti @pe_bartko @orwi @JoaoLCavalcante @BerglerKlein @cshenoy3 #AHAJournals https://t.co/TKGEXDR7j3

[David Ouyang, MD @David_Ouyang]

In anticipation of #ASE21 this weekend, we'd like to share this AI on #EchoFirst. This frame-to-frame measurement of PLAX was fully automated by EchoNet-LVH. More examples and preprint soon! @ASE360 @CedarsSinai

[Cosyns Bernard @Cosyns]

First come first serve for #euroecho on-site in Berlin. Limited number of seats. #eacvi This is one get his inscription! @escardio @alessia_gimelli @denisamuraru @Matte_Cameli @s_e_petersen @ThorEdvardsen @MarcDweck @JGrapsa @EACVIPresident

[The Lancet @TheLancet]

Each 5mmHg reduction in systolic blood pressure lowered the relative risk of cardiovascular events by around 10%.

Authors, @kazemr et al, call for changes to global guidelines. https://t.co/U6O3GdtgZ2 2/2

[Kazem Rahimi @kazemr]

Is raised #bloodpressure (BP) an inevitable and essential process of ageing is it time to remove #hypertension from our vocabulary and manage #CVD risk irrespective of an individual's BP into very old age?

https://t.co/o7Ym5ZKrDZ
https://t.co/6jDfXS06h8

#ESCCongress @TheLancet

[Carlos G Santos-Gallego, MD @SantosGallegoMD]

So proud to have lectured today at #ESCCongress about SGLT2i!

Thanks for the invitation, @escardio!

Session: Meet the Experts: fuel up! – targeting cardiac energy metabolism in type 2 diabetes and HF…

Title: ... By Pharmacological Interventions: SGLT2i in heart failure